Tipping the balance - improving response rates to cancer immunotherapy

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1196605

Funding Status
Status not available

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Survival rates for some types of cancer remain low. It was previously thought that chemotherapy could not be combined with drugs that affect the immune system (immunotherapy) to treat cancer. My research disproved this. I develop models to study cancer in the lab. I also research ways to measure how people’s bodies respond to chemotherapy and immunotherapy (biomarkers). I use this information to discover new drug combinations to reduce deaths from cancer.

Funded Activity Details

Start Date: 01-01-2020

End Date: End date not available

Funding Scheme: Investigator Grants

Funding Amount: $1,562,250.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

cancer immunotherapy | oncology | systems biology | translational research

Related Links